Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05771051 · ClinicalTrials.gov registry record
Australian University of California San Francisco (UCSF) Concussion in Athletes (AUSSIE-2)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 68
- Enrollment target
NCT05771051: Completed study, sponsored by University of California, San Francisco.
NCT05771051 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05771051 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
Analysis of cardiac induced brain forces using cranial accelerometry has been shown to diagnose concussion in high school athletes. This trial expands on this observation by recording headpulse signals in a recently concussed athletes playing Australian rules football.
Primary Outcome
Sensitivity of headpulse measurements confirming concussion
Interventions
- DEVICE Headpulse measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-10-01 |
What the finished NCT05771051 record still lists
NCT05771051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Headpulse measurements is the first listed.
NCT05771051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05771051 about?
NCT05771051 is a clinical study titled "Australian University of California San Francisco (UCSF) Concussion in Athletes (AUSSIE-2)". Analysis of cardiac induced brain forces using cranial accelerometry has been shown to diagnose concussion in high school athletes. This trial expands on this observation by recording headpulse signals in a recently concussed athletes playing Australian rules football.
What is the current status of trial NCT05771051?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2022-03-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT05771051?
The interventions under investigation include: Headpulse measurements (DEVICE).
Who is sponsoring clinical trial NCT05771051?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI